The association of IL-1β, IL-2, and IL-6 gene polymorphisms with bone mineral density and osteoporosis in postmenopausal women

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 149, Issue 1, 2010, Pages 82-85

  Czerny, Bogusław ^a   Kaminski, Adam ^a   Kurzawski, Mateusz ^a   Kotrych, Daniel ^a   Safranow, Krzysztof ^a   Dziedziejko, Violetta ^a   Bohatyrewicz, Andrzej ^a   Pawlik, Andrzej ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Cytokines; Osteoporosis; Polymorphism

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6;

ADULT; AGED; ARTICLE; BONE DENSITY; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; FEMUR NECK; GENETIC ASSOCIATION; GENOTYPE; HETEROZYGOTE; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; SCORING SYSTEM; ALLELE; ANALYSIS OF VARIANCE; GENETICS; NONPARAMETRIC TEST; POLAND; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; ANALYSIS OF VARIANCE; BONE DENSITY; FEMALE; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-2; INTERLEUKIN-6; OSTEOPOROSIS, POSTMENOPAUSAL; POLAND; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTMENOPAUSE; STATISTICS, NONPARAMETRIC;

EID: 76049104004     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2009.12.010     Document Type: Article

References (31)

1. Smith D.M., Nance W.E., Kang K.W., Christian J.C., and Johnston Jr. C.C. Genetic factors in determining bone mass. J Clin Invest 52 (1973) 2800-2808
2. Guéguen R., Jouanny P., Guillemin F., Kuntz C., Pourel J., and Siest G. Segregation analysis and variance components analysis of bone mineral density in healthy families. J Bone Miner Res 10 (1995) 2017-2022
3. Nordstrom P., and Lorentzon R. Influence of heredity and environment on bone density in adolescent boys: a parent-offspring study. Osteoporos Int 10 (1999) 271-277
4. Pocock N.A., Eisman J.A., Hopper J.L., Yeates M.G., Sambrook P.N., and Eberl S. Genetic determinants of bone mass in adults. A twin study. J Clin Invest 80 (1987) 706-710
5. Cummings S.R., Nevitt M.C., Browner W.S., et al. Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med 332 (1995) 767-773
6. Torgerson D.J., Campbell M.K., Thomas R.E., and Reid D.M. Prediction of perimenopausal fractures by bone mineral density and other risk factors. J Bone Miner Res 11 (1996) 293
7. Deng H.W., Chen W.M., Recker S., et al. Genetic Determination of Colles' fracture and differential bone mass in women with and without Colles' fracture. J Bone Miner Res 15 (2000) 1243-1252
8. Kannus P., Palvanen M., Kaprio J., Parkkari J., and Koskenvuo M. Genetic factors and osteoporotic fractures in elderly people: prospective 25 year follow up of nationwide cohort of elderly Finnish twins. BMJ 319 (1999) 1334-1337
9. Ding C., Parameswaran V., Udayan R., Burgess J., and Jones G. Circulating levels of inflammatory markers predict change in bone mineral density and resorption in older adults: a longitudinal study. J Clin Endocrinol Metab 93 (2008) 1952-1958
10. Kurzawski M., Pawlik A., Czerny B., Domański L., Rózański J., and Droździk M. Frequencies of the common promoter polymorphisms in cytokine genes in a Polish population. Int J Immunogenet 32 (2005) 285-291
11. Pawlik A., Kurzawski M., Florczak M., Gawronska Szklarz B., and Herczynska M. IL1beta +3953 exon 5 and IL-2 -330 promoter polymorphisms in patients with rheumatoid arthritis. Clin Exp Rheumatol 23 (2005) 159-164
12. Knudsen S., Harsløf T., Husted L.B., Carstens M., Stenkjaer L., and Langdahl B.L. The effect of interleukin-1alpha polymorphisms on bone mineral density and the risk of vertebral fractures. Calcif Tissue Int 80 (2007) 21-30
13. Kim J.G., Lim K.S., Ku S.Y., Kim S.H., Choi Y.M., and Moon S.Y. Relations between interleukin-1, its receptor antagonist gene polymorphism, and bone mineral density in postmenopausal Korean women. J Bone Miner Metab 24 (2006) 53-57
14. Chen H.Y., Chen W.C., Wu M.C., Tsai F.J., and Lin C.C. Interleukin-1beta and interleukin-1 receptor antagonist gene polymorphism in postmenopausal women: correlation to bone mineral density and susceptibility to osteoporosis. Maturitas 44 (2003) 49-54
15. Pacifici R., Vannice J.L., Rifas L., and Kimble R.B. Monocytic secretion of interleukin-1 receptor antagonist in normal and osteoporotic women: effects of menopause and estrogen/progesterone therapy. J Clin Endocrinol Metab 77 (1993) 1135-1141
16. Manolagans S.C., and Jilka R.L. Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. N Engl J Med 332 (1995) 305-311
17. Ralston S.H. Analysis of gene expression in human bone biopsies by polymerase chain reaction: evidence for enhanced cytokine expression in postmenopausal osteoporosis. J Bone Miner Res 9 (1994) 883-890
18. Scheidt-Nave C., Bismar H., and Leidig-Bruckner G. Serum interleukin 6 is a major predictor of bone loss in women specific to the first decade past menopause. J Clin Endocrinol Metab 86 (2001) 2032-2042
19. O'Brien C.A., Jilka R.L., Fu Q., Stewart S., Weinstein R.S., and Manolagas S.C. IL-6 is not required for parathyroid hormone stimulation of RANKL expression, osteoclast formation, and bone loss in mice. Am J Physiol Endocrinol Metab 289 (2005) 784-793
20. Murray R.E., McGuigan F., Grant S.F., Reid D.M., and Ralston S.H. Polymorphisms of the interleukin-6 gene are associated with bone mineral density. Bone 21 (1997) 89-92
21. Magaña J.J., Gómez R., Cisneros B., Casas L., and Valdés-Flores M. Association of interleukin-6 gene polymorphisms with bone mineral density in Mexican women. Arch Med Res 39 (2008) 618-624
22. Bustamante M., Nogués X., Mellibovsky L., et al. Polymorphisms in the interleukin-6 receptor gene are associated with bone mineral density and body mass index in Spanish postmenopausal women. Eur J Endocrinol 157 (2007) 677-684
23. Moffett S.P., Zmuda J.M., Cauley J.A., et al. SOF Research Group. Association of the G-174C variant in the interleukin-6 promoter region with bone loss and fracture risk in older women. J Bone Miner Res 19 (2004) 1612-1618
24. Ferrari S.L., Karasik D., Liu J., et al. Interactions of interleukin-6 promoter polymorphisms with dietary and lifestyle factors and their association with bone mass in men and women from the Framingham Osteoporosis Study. J Bone Miner Res 19 (2004) 552-559
25. Nordström A., Gerdhem P., Brändström H., et al. Interleukin-6 promoter polymorphism is associated with bone quality assessed by calcaneus ultrasound and previous fractures in a cohort of 75-year-old women. Osteoporos Int 15 (2004) 820-826
26. Huang Q.Y., Shen H., Deng H.Y., et al. Linkage and association of the CA repeat polymorphism of the IL6 gene, obesity-related phenotypes, and bone mineral density (BMD) in two independent Caucasian populations. J Hum Genet 48 (2003) 430-437
27. Yamada Y., Ando F., Niino N., and Shimokata H. Association of polymorphisms of interleukin-6, osteocalcin, and vitamin D receptor genes, alone or in combination, with bone mineral density in community-dwelling Japanese women and men. J Clin Endocrinol Metab 88 (2003) 3372-3378
28. Feng D., Ishibashi H., Yamamoto S., et al. Association between bone loss and promoter polymorphism in the IL-6 gene in elderly Japanese women with hip fracture. J Bone Miner Metab 21 (2003) 225-228
29. Garnero P., Borel O., Sornay-Rendu E., et al. Association between a functional interleukin-6 gene polymorphism and peak bone mineral density and postmenopausal bone loss in women: the OFELY study. Bone 31 (2002) 43-50
30. Kusek J., Seremak-Mrozikiewicz A., Drews K., et al. The influence of interleukin-6 and tumor necrosis factor alpha gene polymorphisms on bone mineral density in postmenopausal women. Ginekol Pol 79 (2008) 426-431
31. Fishman D., Faulds G., Jeffery R., et al. The effect of novel polymorphism in the interleukin 6 gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 102 (1998) 1369-1376